Campbell Alliance Clinical Development Practice to Present Session on Global EDC Rollout at Clinical Trials Congress, Europe
May 14, 2008
Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Gary Tyson, Senior Vice President of the firm’s Clinical Development Practice, will present a session on managing the global rollout of electronic data capture (EDC) systems at Informa’s Clinical Trials Congress, Europe. The event will be held on May 28-29, 2008, at the Olympia Conference Centre in London.
Mr. Tyson’s session, titled “After EDC Implementation: Now What?” is slated for 29 May at 14:50. The session, designed to help clinical leaders understand how organizations can ensure successful uptake of EDC solutions and maximize returns on EDC investments, will cover
- Performing required organizational changes
- Implementing continuous process improvement
- Integrating reporting systems for serious adverse events
- Integrating other e-clinical systems with EDC
“Although the initial rollout of a clinical EDC solution can be cause for celebration, it doesn’t mean that the work is over,” Mr. Tyson said. “To fully realize the potential benefits of EDC, clinical organizations must properly integrate key activities and processes with the system.”
As head of Campbell Alliance’s Clinical Development Practice, Gary Tyson leads a team that provides a range of operational improvement services to clinical development organizations within pharmaceutical and biotech companies, as well as leading contract research organizations (CROs). Mr. Tyson is a veteran of numerous EDC-related initiatives, including helping organizations adopt EDC at the enterprise level, and brings a wealth of knowledge and experience in process improvement, organizational design, and clinical development to his consulting engagements.
About the Clinical Development Practice at Campbell Alliance
Campbell Alliance's Clinical Development Practice includes operations improvement specialists with expertise in clinical development. The practice specializes in helping clients correct or improve the processes that are most often responsible for delays and budget overruns in clinical development. Services include
- Development of outsourcing strategies
- Process improvement for data collection and management, patient recruitment, and
- Organizational development and improvement
- Electronic data capture consulting and implementation support
- Clinical trial analytics
About Campbell Alliance
Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta, and London, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.